Home/Filings/4/0001457612-20-000079
4//SEC Filing

Duvall Diantha 4

Accession 0001457612-20-000079

CIK 0001457612other

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 4:19 PM ET

Size

7.2 KB

Accession

0001457612-20-000079

Insider Transaction Report

Form 4
Period: 2020-06-01
Duvall Diantha
CHIEF FINANCIAL OFFICER
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-06-01+24,93824,938 total
    Exercise: $2.72Exp: 2030-06-01Common Stock (24,938 underlying)
  • Award

    Common Stock

    2020-06-01+6,6236,623 total
Footnotes (2)
  • [F1]Represents restricted stock units granted to the Reporting Person under the Amended and Restated 2014 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest one-fourth (1/4) on each of the first four (4) anniversaries on the date of grant.
  • [F2]The option will vest in 48 equal monthly installments beginning on the first monthly anniversary of the grant date.

Issuer

GENOCEA BIOSCIENCES, INC.

CIK 0001457612

Entity typeother

Related Parties

1
  • filerCIK 0001696784

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:19 PM ET
Size
7.2 KB